A good business idea is the key to success
Whether with cheap gravestones for dogs and cats, everyday pyjamas or remnants from the fast-moving entertainment electronics, with a brilliant idea and perseverance, some have made it to wealth. Courage, perseverance and also luck are surely part of it. The mining industry needs excellent projects in the right regions of the world, experienced management, a secure financial position and the ability to act at the right time, to name just a few.
Osisko Gold Royalties - https://www.commodity-tv.net/c/search_adv/?v=298716 - has established itself in a very special area of the gold mining industry. But not as a classic gold company, but as a precious metal licensing company. The company earns its income from license fee agreements, streams and precious metal acceptances. Osisko Gold Royalties holds interests in listed commodity companies and operates successfully. The company has just been able to reduce its debt by 43 million US dollars. Shareholders are already looking forward to a quarterly dividend 17 times in a row.
In Canada, another opportunity has opened up for entrepreneurs in recent years: the cannabis market. A few months ago, products of the plant were legalized in Canada. Since then, the waves have also been making their mark on the stock markets. RavenQuest BioMed has established itself among the many cannabis companies. Around 80 percent of the production expected for 2019 has already been sold. This is a milestone that will generate revenue for the Company. The company has just secured a 51 per cent stake in 1 Life Cannabis.
Because high-quality cannabis in premium quality is particularly in demand on the market, RavenQuest BioMed attaches particular importance to it. 1 Life will therefore be a valuable addition to the RavenQuest BioMed technology - https://www.commodity-tv.net/c/search_adv/?v=298788. No wonder, then, that Fundamental Research recommends the RavenQuest BioMed share as a buy and uses a fair price of 2.09 US dollars.
Current company information and press releases from RavenQuest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc.html) and Osisko Gold Royalties ( https://www.resource-capital.ch/en/companies/osisko-gold-royalties-ltd.html).
In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the English version of these messages applies.
Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: www.resource-capital.ch/en/disclaimer.html